The US Food and Drug Administration awarded Veinwave clearance to market in June 2009 under reference number K083352. Its indications for use are for the treatment of lower limb spider veins or telangiectasia by thermocoagulation. Veinwave is the only device utilising this technology currently to have been cleared.

This website is an Internaional site offering information and guidance to users of Veinwave worldwide and to those interested in the technique. It may contain references to medical conditions and applications of Veinwave which have not yet been cleared for use in the US. It is imperative that practitioners of Veinwave in the US, and those seeking to become practitioners in the future, are aware of the limitations of use in this region.